Michael S. Perry

Michael S. Perry is a declared insider at 2 companies (senior executive); the most frequent names are Arrowhead Pharmaceuticals, Inc. and AVITA Medical, Inc. We count 17 filings; the first trade dates from 1 January 2016 and the latest from 18 August 2026.

Sales make up the whole of the open-market record (5 sales, €3.2M). Outside the open market, there are 10 share grants and 1 option exercise. Since January 2026: no purchases and 1 sale on the market.

The newest entry dates from 20 August 2026: an open-market sale of €874k, in Arrowhead Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.